Literature DB >> 33232175

Association of White Matter Hyperintensities and Cardiovascular Disease: The Importance of Microcirculatory Disease.

Francesco Moroni1, Enrico Ammirati2, Atticus H Hainsworth3,4, Paolo G Camici1.   

Abstract

Cardiac and cerebrovascular diseases are currently the leading causes of mortality and disability worldwide. Both the heart and brain display similar vascular anatomy, with large conduit arteries running on the surface of the organ providing tissue perfusion through an intricate network of penetrating small vessels. Both organs rely on fine tuning of local blood flow to match metabolic demand. Blood flow regulation requires adequate functioning of the microcirculation in both organs, with loss of microvascular function, termed small vessel disease (SVD) underlying different potential clinical manifestations. SVD in the heart, known as coronary microvascular dysfunction, can cause chronic or acute myocardial ischemia and may lead to development of heart failure. In the brain, cerebral SVD can cause an acute stroke syndrome known as lacunar stroke or more subtle pathological alterations of the brain parenchyma, which may eventually lead to neurological deficits or cognitive decline in the long term. Coronary microcirculation cannot be visualized in vivo in humans, and functional information can be deduced by measuring the coronary flow reserve. The diagnosis of cerebral SVD is largely based on brain magnetic resonance imaging, with white matter hyperintensities, microbleeds, and brain atrophy reflecting key structural changes. There is evidence that such structural changes reflect underlying cerebral SVD. Here, we review interactions between SVD and cardiovascular risk factors, and we discuss the evidence linking cerebral SVD with large vessel atheroma, atrial fibrillation, heart failure, and heart valve disease.

Entities:  

Keywords:  arteries; brain; heart failure; microcirculation; stroke

Mesh:

Year:  2020        PMID: 33232175     DOI: 10.1161/CIRCIMAGING.120.010460

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  6 in total

1.  Meta-analysis of the correlation between serum uric acid level and carotid intima-media thickness.

Authors:  Mingzhu Ma; Liangxu Wang; Wenjing Huang; Xiaoni Zhong; Longfei Li; Huan Wang; Bin Peng; Min Mao
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

2.  Detecting Small Vessel Pathology in Cocaine Use Disorder.

Authors:  Marco Öchsner; Elijah Mak; Karen D Ersche
Journal:  Front Neurosci       Date:  2022-02-10       Impact factor: 4.677

3.  Reduced cerebral vascular fractal dimension among asymptomatic individuals as a potential biomarker for cerebral small vessel disease.

Authors:  Niferiti Aminuddin; Anusha Achuthan; Nur Intan Raihana Ruhaiyem; Che Mohd Nasril Che Mohd Nassir; Nur Suhaila Idris; Muzaimi Mustapha
Journal:  Sci Rep       Date:  2022-07-11       Impact factor: 4.996

Review 4.  Atrial cardiopathy and cognitive impairment.

Authors:  Sarah J Myers; Amado Jiménez-Ruiz; Luciano A Sposato; Shawn N Whitehead
Journal:  Front Aging Neurosci       Date:  2022-07-22       Impact factor: 5.702

Review 5.  Statins and cognition: Modifying factors and possible underlying mechanisms.

Authors:  Tahereh Jamshidnejad-Tosaramandani; Soheila Kashanian; Mohamed H Al-Sabri; Daniela Kročianová; Laura E Clemensson; Mélissa Gentreau; Helgi B Schiöth
Journal:  Front Aging Neurosci       Date:  2022-08-15       Impact factor: 5.702

6.  Prevalence and incidence of stroke, white matter hyperintensities, and silent brain infarcts in patients with chronic heart failure: A systematic review, meta-analysis, and meta-regression.

Authors:  Sean Tan; Clare Elisabeth Si Min Ho; Yao Neng Teo; Yao Hao Teo; Mark Yan-Yee Chan; Chi-Hang Lee; Lauren Kay Mance Evangelista; Weiqin Lin; Yao-Feng Chong; Tiong-Cheng Yeo; Vijay Kumar Sharma; Raymond C C Wong; Benjamin Y Q Tan; Leonard L L Yeo; Ping Chai; Ching-Hui Sia
Journal:  Front Cardiovasc Med       Date:  2022-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.